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Background: Among patients with chronic unexplained cough, there is a recognized subgroup
with respiratory symptoms induced by environmental irritants like chemicals and odours. The
diagnosis of sensory hyperreactivity (SHR) has been suggested for this group of patients and can
be made using a tidal breathing capsaicin inhalation test. The aim of the present study was to
evaluate the ability of a single-breath, dose-response capsaicin threshold test to discriminate
such patients from control subjects.
Methods: A total of 46 patients with chronic cough and SHR who had previously shown a pos-
itive reaction in accordance with limits set for a tidal breathing capsaicin test were tested
once with a single-breath, dose-response capsaicin cough threshold test, assessing capsaicin
concentrations to evoke 2 (C2), 5 (C5) or 10 (C10) coughs. Twenty-nine subjectively healthy
control subjects were also included and tested with the threshold method.
Results: Patients had significantly lower C2, C5 and C10 in comparison to controls. From the
results among patients and controls, sensitivity and specificity were calculated, and a receiver
operating characteristic curve was constructed, showing excellent ability for C5 and C10 to
discriminate patients from control subjects.
Conclusions: For patientswith SHR and chronic cough, capsaicin cough sensitivitywas once again
confirmed to be increased, in this case, using the single-breath dose-responsemethod. Limits set
for cough reactions regarded as more sensitive than normal can be useful in diagnostics and
further research. C5 seems to be the bestmeasure to use in research and differential diagnostics.
ª 2014 Elsevier Ltd. All rights reserved.3423635; fax: þ46 31 417824.
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Inhaled capsaicin (8-methyl-N-vanillyl-6-nonenamide) has
long been used to induce cough in a safe and dose-
dependent manner, and the degree of induced cough re-
flects the reactivity of sensory C-fibres in the respiratory
mucosa [1e4]. In cough research the use of capsaicin has
been important, and has good short- and long-term
reproducibility [5e12]. The most commonly used method
to assess capsaicin cough sensitivity is the single-breath
dose-response method: Doubling doses are given at 1-min
intervals to assess the cough thresholds, stating the con-
centration of capsaicin causing 2 (C2), 5 (C5), or 10 or
more (C10) coughs during the 1-min period between each
dose. This single-breath method is recommended in the
European Respiratory Societies (ERS) guidelines [13], and
some studies suggest that C5 is the clinically superior
value [6].
It has been suggested that patients with upper and lower
airway symptoms induced by odours and chemicals, such as
flower scents, perfume, cleaning agents, car exhaust fumes
and tobacco smoke, suffer from airway sensory hyperre-
activity (SHR) [5]. Common symptoms are cough, hoarse-
ness, difficulty in getting air, rhinorrhoea, and eye
irritation. Most of these patients could also be diagnosed
with chronic cough, having coughing that persists for more
than 8 weeks [4,11]. The symptoms may be misinterpreted
as asthma and/or allergy, except that the clinical picture
shows no bronchial obstruction or IgE-mediated reactions.
Such patients are often diagnosed as having idiopathic or
unexplained chronic cough, and might also be included in
the newly established cough hypersensitivity syndrome
[14e18]. In a recent report there was a high degree of
agreement among opinion leaders as to the concept that
cough hypersensitivity underlies the aetiology of chronic
cough in the majority of patients [19].
Stimulation of the unmyelinated C-fibres of the trigem-
inal and vagal nerves is likely involved in chemical-induced
airway symptoms [20,21]. In line with the hypothesis of
SHR, these patients react to inhaled capsaicin with more
coughing and other symptoms than healthy individuals and
asthmatic patients, and the reactions can be blocked by
preinhalation of a local anaesthetic [5,22]. The suggested
diagnosis of SHR can, together with pronounced airway
symptoms from scents and chemicals, be assessed using a
standardized capsaicin inhalation test to identify patients
and to differentiate between healthy subjects, patients
with asthma and those with SHR [23,24]. In this test, in-
cremental concentrations of capsaicin are inhaled to
induce coughing using a tidal breathing method, and limits
for the number of coughs in a normal reaction are set. This
capsaicin inhalation test has shown good reproducibility
using a simple device for tidal breathing (Pari Boy or Maxin
MA3), and no influence on lung function has been found
[5,23,24]. However, for research purposes, and in clinics
with access to more sophisticated nebulizer systems, the
single-breath method may have advantages, giving more
specified data on delivered aerosol and being in accordance
with ERS guidelines. In this study we aimed to evaluate the
extent to which capsaicin inhalation testing in conjunction
with the single-breath dose-response method candistinguish patients with chronic cough and SHR from
healthy control subjects.
Methods
Patient group
The study group included 46 non-smoking patients, 41
women and 5 men, 21e74 years of age (mean 56 years).
They were referred to an asthma and allergy outpatient
clinic because of cough and airway symptoms suggestive of
asthma or allergy. The patients were screened using a
questionnaire on airway symptoms and on symptoms in
response to environmental irritants, and all had a history of
at least two years of coughing and pronounced upper and/
or lower airway symptoms induced by irritants like chem-
icals and scents. They had within the previous five years
had positive reactions to a capsaicin inhalation test
administered with the tidal breathing method according to
the method described by Johansson et al. [23], and were
diagnosed as having SHR as an explanation for their airway
symptoms. All patients had negative skin-prick test results
when tested with a standard panel of 10 allergens in sour-
ces common to Sweden and had also undergone a meth-
acholine test within the previous five years. The
methacholine test was performed in accordance with in-
ternational guidelines [25] and was negative for all pa-
tients, indicating the absence of bronchial asthma.
The patients were asked to take no medication for at
least 4 h, and no long-acting b2-agonists for at least 72 h,
prior to the inhalation tests.
Control group
The control group consisted of 29 non-smoking, subjec-
tively healthy individuals, 25 women and 4 men, 27e66
years of age (mean 52 years). They were also screened
using questions on airway symptoms and on symptoms in
response to chemicals and scents. None had a history of
asthma, allergies or airway symptoms in response to envi-
ronmental irritants, and none was taking any medication
for the airways.
Study design
Each participant visited the clinic once and was tested with
a single-breath capsaicin provocation. The cough thresholds
of the study participants were registered manually during
the provocations. Cough was defined as the characteristic
sound that follows a forced expiratory effort against a
closed glottis and distinguished from other sounds such as
clearing the throat [13,26], by a discretionary decision of
the investigator upon observation of the subjects. The total
time for each provocation was about 15 min.
Provocations were not carried out on subjects who had
experienced respiratory infections in the past month.
The participants could not be using angiotensin-
converting enzyme inhibitors or any medication for
gastro-oesophageal reflux. Pregnancy and breastfeeding
were exclusion criteria.
Figure 1 Mean log concentrations (mmol/L) of capsaicin
eliciting 2 (C2), 5 (C5) or 10 or more (C10) coughs in 46 patients
with chronic cough and SHR and in 29 control subjects. Error
bars represent 95% confidence intervals (CI).
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and controls after they were provided with verbal and
written information. The Regional Ethics Review Board of
Gothenburg, Sweden, approved the study.
Capsaicin solutions
A stock solution of capsaicin (SigmaeAldrich, Sweden AB,
Stockholm, M2028) [1 mmol/L in ethanol (99.5%)] was
prepared and then dissolved in 0.9% saline to provide a
stock solution of 500 mmol/L capsaicin. Fresh serial di-
lutions were prepared from this stock solution, using saline
diluent to produce doubling concentrations from 0.49 to
500 mmol/L.
Capsaicin provocation with the single-breath
method
Doses were administered from a compressed airedriven
sidestream nebulizer (MedicAid Pro, Sussex, UK) controlled
by an aerosol provocation system (APS version 5.02 soft-
ware, Viasys Healthcare GmbH, Hoechberg, Germany). The
nebulizer’s output was 240 mg/min, and the mass median
particle diameter was 3.2 mm. The duration of aerosol de-
livery was programmed to 0.4 s, thereby providing
0.0016 ml per breath. The subjects inhaled, without a nose
clip, three single, vital capacity breaths before the capsa-
icin solution was ejected in the fourth inhalation. Doubling
doses were given at 1-min intervals, and the concentration
of capsaicin causing 2 (C2), 5 (C5) or 10 or more (C10)
coughs during the 1-min period between each concentra-
tion was registered. A value of 1000 mmol/L capsaicin was
assigned if C2, C5 and/or C10 values were >500 mmol/L.
In all participants the forced expiratory volume during
1 s (FEV1) was measured using a MasterScope (version 4.67
software, Viasys Healthcare GmbH, Hoechberg, Germany)
before and after each completed capsaicin provocation.
The participants used a nose clip, and the higher of two
values was recorded.
Statistical analysis
The Wilcoxon signed-rank test was used for paired data. For
comparison between groups Fisher’s exact test was used for
dichotomous variables and the ManneWhitney U-test was
used for continuous variables. All tests were two-tailed and
results were considered significant if P <0.05. Data were
analysed using version 16.0 of the SPSS software package
(SPSS Inc., Chicago, IL, USA) and SASD 9.2 (SAS Institute
Inc., Cary, NC, USA).
The single-breath method was evaluated by constructing
a receiver operating characteristic (ROC) curve, in which
sensitivity versus 1-specificity for each possible cough cut-
off level was plotted [27,28]. If the area under the curve is
0.5, this suggests no discrimination. An area under the
curve of more than 0.9 indicates that a method has
outstanding discrimination ability, for example, the ability
to distinguish two groups from each other [29]. A corre-
sponding value of more than 0.8 indicates excellent
discrimination ability, and more than 0.7 is considered as
acceptable discrimination ability.All data were recorded by subject numbers, so the au-
thors and the statistician did not know the identity of the
patients.Results
Patients and controls coughed dose-dependently in terms
of growing cough reaction with increasing capsaicin con-
centrations. The cough thresholds for C2, C5 and C10 were
significantly lower in patients compared to controls
(P < 0.005 for C2 and P < 0.0001 for C5 and C10) (Fig. 1).
The mean value of FEV1 before the capsaicin provoca-
tion was 106% of predicted value (95% CI: 101e110) among
the patients and 101% of predicted value (95% CI: 93e109)
among the controls (ns). The results did not differ signifi-
cantly between recordings before and those after the
provocations (data not shown) in either group.Ability to distinguish patients from controls
Based on values for sensitivity and specificity with different
“cut-offs”, limits for a positive test were suggested for the
capsaicin concentrations that evoked C2, C5 and C10.
C2
From the individual threshold results a limit for a positive
test was set when C2 was evoked from a capsaicin con-
centration of <2 mmol/L, giving sensitivity for C2 of 0.65
and a specificity of 0.66.
C5
The corresponding limit for C5 was set to a capsaicin con-
centration of <15.6 mmol/L, giving sensitivity for C5 of 0.96
and a specificity of 0.86.
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For C10 the cut-off limit was set to a capsaicin concentra-
tion of <125 mmol/L, giving a sensitivity of 0.91 and a
specificity of 0.97.
Fig. 2 shows ROC curves for C2, C5 and C10 using the
single-breath method. The area under the curve for C2 was
0.71 (considered as acceptable discrimination ability), and
for C5 and C10 the area was 0.97 and 0.98, respectively
(both considered as outstanding discrimination ability) [29].
The results indicate C5 and C10 as the best choices for
discriminating patients from healthy subjects.Discussion
The main findings in this study were that SHR patients
previously diagnosed with a tidal breathing inhalation
capsaicin cough test had significantly lower C2, C5 and C10
in comparison to controls using a single-breath dose-
response method. From the cough threshold outcomes
among patients and controls, sensitivity and specificity
were calculated, and a ROC curve was constructed showing
excellent ability for both C5 and C10 to discriminate pa-
tients from control subjects, even better ability in this
aspect than earlier results with the tidal breathing method
[8]. The corresponding curve for C2 demonstrated less
discrimination ability, and C2 also had large individual
divergence. Limits for discrimination of patients from
healthy controls were set and could be of use in the future.Figure 2 ROC curves of optimal cough cut-off levels to
distinguish patients with SHR from healthy controls based on
mean concentrations of capsaicin (mmol/L) to reach 2 coughs
(C2), 5 coughs (C5) or 10 coughs (C10) by the single-breath
dose-response method in 46 patients with chronic cough and
SHR and in 29 control subjects.The ROC curve is often used to evaluate whether a
method can distinguish patients from healthy subjects, and
in this study the single breath method of capsaicin inhala-
tion showed a high degree of such discrimination ability.
However, attention must be paid to the previously known
increased capsaicin cough reaction with the tidal breathing
method among patients e a necessary qualification to the
study. To evaluate a method without introducing bias, no
such assumptions should be set, but the current results
show that the threshold method has a corresponding good
ability to distinguish patients.
Increased cough sensitivity to capsaicin has been found
in patients with several reasons for chronic cough. Patients
with gastro-oesophageal reflux [30,31], bronchitis, chronic
obstructive pulmonary disease [32e34] and pulmonary
fibrosis [35] have shown increased cough sensitivity to
inhaled capsaicin, while for asthmatics, the results are
more contradictory [5,24,32e34,36]. When using a capsa-
icin inhalation test to identify SHR patients, it is important
to carefully exclude other diagnoses that may influence the
cough sensitivity. On the other hand, patients with unex-
plained chronic cough should be questioned about chemical
sensitivity as an inducing factor, in light of results showing a
majority of a group of patients with chronic unexplained
cough having chemicals and scents as inducing factors and
being positive to a capsaicin inhalation test [37,38]. The
narrow selection of chronic cough patients in the present
study, all having cough induced by environmental irritants,
may explain why in contradiction to other reports [31,39],
the capsaicin cough threshold test showed excellent ability
to discriminate patients from healthy control subjects.
The recently introduced cough hypersensitivity syn-
drome throws new light on cough evoked from environ-
mental stimuli with origin in diverse respiratory conditions
and emphasizes the value of capsaicin use in cough research
[14e19]. The current results are in accordance with the ERS
guidelines recommending the single-breath method as
preferable [13], and now this method has proven to be useful
also in diagnosing and studying chronic cough related to SHR.
Further, the clinical impression from the provocations was
that the method was easy handled and quick to carry out,
and caused few symptoms among the participants. A disad-
vantage, however, is that the necessary equipment is
expensive and requires some expert knowledge.
With regard to the present findings of high sensitivity
and specificity for C5 and C10, the cut-off limits for these
thresholds seem to be preferable to the limit for C2. We
also found a variety among the control subjects for C2,
indicating a difficulty in separating patients from healthy
individuals that is in accordance with other researchers’
findings of less reproducibility for C2 [6]. Using C5 seems to
be the simplest way to assign heightened capsaicin cough
sensitivity also in regard to the short time needed to
perform the provocation and the minor trouble caused to
the patient, and is further in agreement with earlier sug-
gestions [6]. With regard to many earlier reports of safety
and reproducibility of capsaicin cough sensitivity
[5e12,40], this method seems harmless and trustable. As
both the tidal breathing and the threshold method have
proven in several earlier studies to have good short- and
long-time reproducibility [5e12,40], this aspect was not
evaluated in the present study.
Capsaicin cough threshold test in diagnostics 1375We conclude that in patients with SHR and chronic
cough, capsaicin cough sensitivity is once again confirmed
to be increased, in this study using the single-breath dose-
response method, and to discriminate SHR patients from
subjectively healthy individuals. Limits set for cough re-
actions assessed as more sensitive than normal can be
useful in further research.
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